Azurity Pharmaceuticals

Woburn, United States Founded: 1999 • Age: 27 yrs
Generic drugs are manufactured by Azurity Pharmaceuticals in the US.
Request Access

About Azurity Pharmaceuticals

Azurity Pharmaceuticals is a company based in Woburn (United States) founded in 1999.. Azurity Pharmaceuticals has raised $20 million across 1 funding round from investors including Ampersand Capital Partners. Azurity Pharmaceuticals has completed 4 acquisitions, including Arbor pharma, Covis Pharma and Silvergate Pharma. Azurity Pharmaceuticals offers products and services including XIFYRM and FIRVANQ.

  • Headquarter Woburn, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Azurity Pharmaceuticals, Inc
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $64.85 K (USD)
    -33
    as on Jul 26, 2023
  • Net Profit
    $40.74 K (USD)
    -41
    as on Jul 26, 2023
  • EBITDA
  • Total Equity Funding
    $20 M (USD)

    in 1 rounds

  • Latest Funding Round
    $20 M (USD), Series A

    Dec 30, 2014

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Azurity Pharmaceuticals

Azurity Pharmaceuticals offers a comprehensive portfolio of products and services, including XIFYRM and FIRVANQ. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

An IV non-steroidal anti-inflammatory drug is offered for the management of moderate-to-severe pain in adults

A product is provided for treating bacterial infections, forming part of the company's diversified pharmaceutical offerings

Funding Insights of Azurity Pharmaceuticals

Azurity Pharmaceuticals has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series A round of $20 million completed in December 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $20.0M
  • First Round

    (30 Dec 2014)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2014 Amount Series A - Azurity Pharmaceuticals Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Azurity Pharmaceuticals

Azurity Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ampersand Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Azurity Pharmaceuticals

Azurity Pharmaceuticals has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Arbor pharma, Covis Pharma and Silvergate Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses
2011
Specialty generic drugs are manufactured with focus on complex injectables.
2011
Pharmaceutical products for pediatric patients are manufactured by the company.
2010
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Azurity Pharmaceuticals

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Azurity Pharmaceuticals Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Azurity Pharmaceuticals

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Azurity Pharmaceuticals

Frequently Asked Questions about Azurity Pharmaceuticals

When was Azurity Pharmaceuticals founded?

Azurity Pharmaceuticals was founded in 1999 and raised its 1st funding round 15 years after it was founded.

Where is Azurity Pharmaceuticals located?

Azurity Pharmaceuticals is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.

Is Azurity Pharmaceuticals a funded company?

Azurity Pharmaceuticals is a funded company, having raised a total of $20M across 1 funding round to date. The company's 1st funding round was a Series A of $20M, raised on Dec 30, 2014.

What is the annual revenue of Azurity Pharmaceuticals?

Annual revenue of Azurity Pharmaceuticals is $64.85K as on Jul 26, 2023.

What does Azurity Pharmaceuticals do?

Azurity Pharmaceuticals was founded in 1999 and is headquartered in Woburn, United States. Operations are conducted in the pharmaceutical sector, with a focus on the production of generic drugs. Manufacturing processes are centered on developing and supplying affordable medications to meet market needs. The companys domain, azurity.com, supports its digital operations and information dissemination. Geographic activities remain primarily within the United States.

What products or services does Azurity Pharmaceuticals offer?

Azurity Pharmaceuticals offers XIFYRM and FIRVANQ.

How many acquisitions has Azurity Pharmaceuticals made?

Azurity Pharmaceuticals has made 4 acquisitions, including Arbor pharma, Covis Pharma, and Silvergate Pharma.

Who are Azurity Pharmaceuticals's investors?

Azurity Pharmaceuticals has 1 investor. Key investors include Ampersand Capital Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available